{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T17:10:46Z","timestamp":1707066646414},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T00:00:00Z","timestamp":1398384000000},"content-version":"vor","delay-in-days":3005,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1157\/13085351","type":"journal-article","created":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T18:35:14Z","timestamp":1149186914000},"page":"167-172","source":"Crossref","is-referenced-by-count":2,"title":["Actitud ante una mujer posmenop\u00e1usica que consulta por sofocos y dispareunia"],"prefix":"10.1016","volume":"37","author":[{"given":"D.","family":"S\u00e1nchez-Mariscal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bail\u00f3n-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13085351_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-137-10-200211190-00009","article-title":"Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials","volume":"137","author":"Kronenberg","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1157\/13085351_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-5122(02)00024-5","article-title":"The nature and utility of the phytoestrogens: a review of the evidence","volume":"42","author":"Albertazzi","year":"2002","journal-title":"Maturitas"},{"key":"10.1157\/13085351_bib3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/00006842-199911000-00023","article-title":"Attitudes toward menopause and aging across ethnic\/racial groups","volume":"61","author":"Sommer","year":"1999","journal-title":"Psychosom Med"},{"key":"10.1157\/13085351_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0277-9536(00)00147-7","article-title":"Is there a menopausal syndrome? Menopausal status and symptoms across racial\/ethnic groups","volume":"52","author":"Avis","year":"2001","journal-title":"Soc Sci Med"},{"key":"10.1157\/13085351_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1258\/136218002100321965","article-title":"Symptom reporting at menopause: a review of crosscultural findings","volume":"8","author":"Lock","year":"2002","journal-title":"Br Menopause Soc"},{"key":"10.1157\/13085351_bib6","first-page":"329","article-title":"Influencia de las actitudes, expectativas y creencias en la adaptaci\u00f3n a la menopausia","volume":"8","author":"De la G\u00e1ndara","year":"2003","journal-title":"An Psiquiatr"},{"key":"10.1157\/13085351_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00042192-199906020-00008","article-title":"The North American Menopause Society 1998, Menopause Survey. Part I: postmenopausal women's perceptions about menopause and midlife","volume":"6","author":"Utian","year":"1999","journal-title":"Menopause"},{"key":"10.1157\/13085351_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0212-6567(01)78765-3","article-title":"Women's attitudes to menopause and predictive variables","volume":"27","author":"Delgado","year":"2001","journal-title":"Aten Primaria"},{"key":"10.1157\/13085351_bib9","series-title":"Mujeres y Salud en la Comunidad Aut\u00f3noma de Euskadi","year":"1993"},{"key":"10.1157\/13085351_bib10","unstructured":"La menopausia en la Comunidad de Madrid. Aspectos socio-sanitarios. Madrid: Consejer\u00eda de Sanidad y Asuntos Sociales. Comunidad de Madrid. Documentos T\u00e9cnicos de Salud P\u00fablica; 1996."},{"key":"10.1157\/13085351_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0378-5122(95)00985-X","article-title":"The normal menopause transition: an overview","volume":"23","author":"McKinlay","year":"1996","journal-title":"Maturitas"},{"key":"10.1157\/13085351_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1207\/S15327558IJBM0901_04","article-title":"Changes in physical symptoms during the menopause transition","volume":"9","author":"Brown","year":"2002","journal-title":"Int J Behav Med"},{"key":"10.1157\/13085351_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0277-9536(00)00147-7","article-title":"Is there a menopausal syndrome? Menopausal status and symptoms across racial\/ethnic groups","volume":"52","author":"Avis","year":"2001","journal-title":"Soc Sci Med"},{"key":"10.1157\/13085351_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0029-7844(00)00930-3","article-title":"A prospective population-based study of menopausal symptoms","volume":"96","author":"Dennerstein","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1157\/13085351_bib15","series-title":"The Cochrane Library, Issue 1","article-title":"Oral oestrogen replacement therapy versus placebo for hot flushes (Cochrane Review)","author":"MacLennan","year":"2004"},{"key":"10.1157\/13085351_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/01.GME.0000070526.74726.8A","article-title":"Percutaneous 17-beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women","volume":"10","author":"Archer","year":"2003","journal-title":"Menopause"},{"key":"10.1157\/13085351_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/09513590009167695","article-title":"Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application: a randomized, double-blind, placebo-controlled study. Italian Menopause Research Group","volume":"14","author":"Rovati","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1157\/13085351_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9378(00)70483-2","article-title":"Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause","volume":"182","author":"Notelovitz","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1157\/13085351_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-5122(01)00251-1","article-title":"The influence of tibolone on quality of life in postmenopausal women","volume":"41","author":"Meeuwsen","year":"2002","journal-title":"Maturitas"},{"key":"10.1157\/13085351_bib20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1471-0528.2002.02020.x","article-title":"Doseresponse analysis of effects of tibolone on climacteric symptoms","volume":"109","author":"Landgren","year":"2002","journal-title":"BJOG"},{"key":"10.1157\/13085351_bib21","first-page":"596","article-title":"The alternative to hormonal treatment of menopausal vasomotor flushes: veralipride","volume":"59","author":"Wesel","year":"1983","journal-title":"Sem Hop"},{"key":"10.1157\/13085351_bib22","first-page":"1213","article-title":"The treatment of the climacteric syndrome with a combination of low- dose clonidine and low-dose conjugated estrogens","volume":"102","author":"Schindler","year":"1984","journal-title":"Fortschr Med"},{"key":"10.1157\/13085351_bib23","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/jcem-58-6-1158","article-title":"A double blind study to evaluate the effect of methyldopa on menopausal vasomotor flushes","volume":"58","author":"Hammond","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1157\/13085351_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0029-7844(02)02712-6","article-title":"Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial","volume":"101","author":"Guttuso","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1157\/13085351_bib25","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"10.1157\/13085351_bib26","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in treatment of menopausal hot flashes","volume":"289","author":"Stearns","year":"2003","journal-title":"JAMA"},{"key":"10.1157\/13085351_bib27","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1157\/13085351_bib28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0029-7844(98)00175-6","article-title":"Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee","volume":"92","author":"Cardozo","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1157\/13085351_bib29","series-title":"The Cochrane Library, Issue 4","article-title":"Local estrogen for vaginal atrophy in postmenopausal women (Cochrane Methodology Review)","author":"Suckling","year":"2003"},{"key":"10.1157\/13085351_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-5122(95)00955-8","article-title":"Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women","volume":"23","author":"Bygdeman","year":"1996","journal-title":"Maturitas"},{"key":"10.1157\/13085351_bib31","first-page":"43","article-title":"Symptoms and the menopause. International Position Paper on Women's Health and Menopause: a comprehensive Approach","author":"Dennerstein","year":"2002","journal-title":"National Institutes of Health"},{"key":"10.1157\/13085351_bib32","first-page":"330","article-title":"Prevalence of handwashing incontinence in females in comparison with stress and urge incontinence","volume":"9","author":"Kondo","year":"1990","journal-title":"Neurourology & Urodynamics"},{"key":"10.1157\/13085351_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/713605090","article-title":"Longitudinal study of hormone levels and depression among women transitioning through menopause","volume":"4","author":"Avis","year":"2001","journal-title":"Climacteric"},{"key":"10.1157\/13085351_bib34","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0277-9536(01)00326-4","article-title":"Change in psychological and vasomotor symptom reporting during the menopause","volume":"55","author":"Hardy","year":"2002","journal-title":"Soc Sci Med"},{"key":"10.1157\/13085351_bib35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/01.WNL.0000079051.91602.E2","article-title":"A population-based longitudinal study of cognitive functioning in the menopausal transition","volume":"61","author":"Meyer","year":"2003","journal-title":"Neurology"},{"key":"10.1157\/13085351_bib36","first-page":"330","article-title":"Prevalence of handwashing incontinence in females in comparison with stress and urge incontinence","volume":"9","author":"Kondo","year":"1990","journal-title":"Neurourology & Urodynamics"},{"key":"10.1157\/13085351_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/beem.2000.0067","article-title":"Fractures in the elderly: epidemiology and demography","volume":"14","author":"De Laet","year":"2000","journal-title":"Baillieres Best Pract Res Clin Endocrinol Metab"},{"key":"10.1157\/13085351_bib38","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1359\/jbmr.2002.17.7.1237","article-title":"International variations in hip fracture probabilities: implications for risk assessment","volume":"17","author":"Kanis","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1157\/13085351_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s001980170072","article-title":"An assessment tool for predicting fracture risk in postmenopausal women","volume":"12","author":"Black","year":"2001","journal-title":"Osteoporos Int"},{"issue":"Suppl 739","key":"10.1157\/13085351_bib40","first-page":"1","article-title":"Bone density measurement \u2013 A systematic revies. Report from SBU. The Swedish Council on Technology Assesment in Health Care","volume":"241","year":"1997","journal-title":"J Intern Med"},{"key":"10.1157\/13085351_bib41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Inititive Randomized Controlled Trial","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13085351_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.GME.0000086467.82759.DA","article-title":"Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA)study","volume":"10","author":"Barrett-Connor","year":"2003","journal-title":"Menopause"},{"key":"10.1157\/13085351_bib43","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Restricciones terap\u00e9uticas de la terapia hormonal sustitutiva en la menopausia. Nota informativa 2004\/01, febrero de 2004."},{"key":"10.1157\/13085351_bib44","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0002-9149(88)90558-9","article-title":"Contributions of the Framingham Study to the conquest of coronary artery disease","volume":"62","author":"Kannel","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1157\/13085351_bib45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0021-9681(78)90073-5","article-title":"Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project","volume":"31","year":"1978","journal-title":"J Chronic Dis"},{"key":"10.1157\/13085351_bib46","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(97)11321-6","article-title":"Myth and paradox of coronary risk and the menopause","volume":"351","author":"Tunstall-Pedoe","year":"1998","journal-title":"Lancet"},{"key":"10.1157\/13085351_bib47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jama.283.4.534","article-title":"Postmenopausal estrogens opposed, unopposed or none of the above","volume":"283","author":"Willett","year":"2000","journal-title":"JAMA"},{"key":"10.1157\/13085351_bib48","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMsb022365","article-title":"Understanding the divergent data on postmenopausal hormone therapy","volume":"348","author":"Grodstein","year":"2003","journal-title":"N Engl J M"},{"key":"10.1157\/13085351_bib49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/bmj.325.7371.987","article-title":"Second long term HRT trial stopped early","volume":"325","author":"White","year":"2002","journal-title":"BMJ"},{"key":"10.1157\/13085351_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13085351_bib51","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1157\/13085351_bib52","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis","volume":"343","author":"Herrington","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1157\/13085351_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Grady","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13085351_bib54","first-page":"363","article-title":"La soberbia de la medicina preventiva","volume":"167","author":"Sackett","year":"2002","journal-title":"CMAJ"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656706703201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656706703201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T16:44:47Z","timestamp":1707065087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656706703201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0212656706703201"],"URL":"https:\/\/doi.org\/10.1157\/13085351","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}